v3.26.3
Business Segments
 6 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Business Segments Business Segments
Segment information has been prepared in accordance with the Segment Reporting topic of FASB ASC 280. Our reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. The primary measure used by our chief operating decision maker ("CODM") to evaluate the performance of our operating segments and allocate resources to these segments is contribution margin, which we define as gross profit less advertising and marketing expenses. Information regarding total assets by operating segment is not provided to our CODM. Our CODM is our Chief Executive Officer.

The tables below summarize information about our reportable segments.
Three Months Ended September 30, 2026
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$271,812 $64,495 $336,307 
Cost of sales132,992 30,777 163,769 
Gross profit138,820 33,718 172,538 
Advertising and marketing40,488 11,738 52,226 
Contribution margin$98,332 $21,980 $120,312 
Other operating expenses39,600 
Operating income$80,712 
* Intersegment revenues of $0.9 million were eliminated from the North American OTC Healthcare segment.

Six Months Ended September 30, 2026
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$498,018 $103,999 $602,017 
Cost of sales243,257 50,034 293,291 
Gross profit254,761 53,965 308,726 
Advertising and marketing69,418 17,476 86,894 
Contribution margin$185,343 $36,489 $221,832 
Other operating expenses88,600 
Operating income$133,232 
* Intersegment revenues of $1.6 million were eliminated from the North American OTC Healthcare segment.

Three Months Ended September 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$230,756 $43,358 $274,114 
Cost of sales102,348 20,187 122,535 
Gross profit 128,408 23,171 151,579 
Advertising and marketing32,033 6,668 38,701 
Contribution margin$96,375 $16,503 $112,878 
Other operating expenses33,208 
Operating income$79,670 
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.
Six Months Ended September 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$443,334 $80,310 $523,644 
Cost of sales194,526 37,208 231,734 
Gross profit 248,808 43,102 291,910 
Advertising and marketing60,987 12,651 73,638 
Contribution margin$187,821 $30,451 $218,272 
Other operating expenses66,846 
Operating income$151,426 
* Intersegment revenues of $1.2 million were eliminated from the North American OTC Healthcare segment.

In connection with the acquisition of the OTC Wellness Business, the Company established a new product category, Wellness, Sleep & Other, and renamed certain existing product categories. As a result, certain brands were reclassified among product categories. Prior period amounts have been reclassified to conform to the current period presentation.

The tables below summarize information about our segment revenues from similar product groups.

Three Months Ended September 30, 2026
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Cough, Cold & Allergy$27,221 $9,101 $36,322 
Dermatologicals34,274 9,584 43,858 
Eye & Ear Care29,165 5,448 34,613 
Gastrointestinal43,958 19,156 63,114 
Oral Care22,869 3,731 26,600 
Pain Relief29,223 1,667 30,890 
Wellness, Sleep & Other37,201 10,120 47,321 
Women's Health47,901 5,688 53,589 
Total segment revenues$271,812 $64,495 $336,307 
Six Months Ended September 30, 2026
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Cough, Cold & Allergy$42,849 $14,778 $57,627 
Dermatologicals64,889 12,164 77,053 
Eye & Ear Care57,504 10,087 67,591 
Gastrointestinal91,099 34,217 125,316 
Oral Care41,327 7,631 48,958 
Pain Relief55,448 2,244 57,692 
Wellness, Sleep & Other49,760 11,888 61,648 
Women's Health95,142 10,990 106,132 
Total segment revenues$498,018 $103,999 $602,017 
Three Months Ended September 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Cough, Cold & Allergy$20,472 $6,813 $27,285 
Dermatologicals32,792 2,904 35,696 
Eye & Ear Care29,387 4,790 34,177 
Gastrointestinal46,413 17,787 64,200 
Oral Care21,039 3,728 24,767 
Pain Relief27,232 1,501 28,733 
Wellness, Sleep & Other6,127 277 6,404 
Women's Health47,294 5,558 52,852 
Total segment revenues$230,756 $43,358 $274,114 
Six Months Ended September 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Cough, Cold & Allergy$33,825 $12,467 $46,292 
Dermatologicals60,644 5,161 65,805 
Eye & Ear Care57,168 9,317 66,485 
Gastrointestinal90,109 31,875 121,984 
Oral Care39,193 7,276 46,469 
Pain Relief54,490 3,175 57,665 
Wellness, Sleep & Other10,853 659 11,512 
Women's Health97,052 10,380 107,432 
Total segment revenues$443,334 $80,310 $523,644